The increasing demand for controlled immunological investigation and therapeutic design has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using various expression systems, including prokaryotic hosts, mammalian cell lines, and